ClinicalTrials.gg

Program

HH-006

A development code.

Its studies are mostly in Hepatitis B, Chronic · Hepatitis B, led by Huahui Health.

Furthest: phase 2, since Apr 2, 20263 company-led studies, 1 open or runningNext primary completion: Feb 28, 2028 (phase 2)

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Huahui Health31 open or runningphase 2since Apr 2, 2026Mar 2, 2022Feb 28, 2028phase 2 · NCT07519330

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

  1. Mar 2, 2022First study: phase 1 study in Hepatitis BFirst studyNCT05275465 · 33 enrolled · Australia
  2. Mar 25, 2026Phase 1 study in Hepatitis B, ChronicNCT07515209 · 36 enrolled · China
  3. Apr 2, 2026Phase 2 study in Hepatitis B, ChronicPhase 2 reachedNCT07519330 · 45 planned · China

Ahead

  1. Feb 28, 2028Primary completion: phase 2 study in Hepatitis B, ChronicNCT07519330

TargetBeta

Not stated by its company or a source we have read. Most early programs say nothing of it.

Studies

All 3 led by companies developing it, newest first. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT07519330Hepatitis B, Chronic · China2RecruitingFeb 28, 202845
NCT07515209Hepatitis B, Chronic · China1CompletedDec 15, 202536
NCT05275465Hepatitis B · Australia1CompletedDec 29, 202233

How it is read

Names in the registry

  • “HH-006”, 3 entries

Codes read as this program: HH006.

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.